中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
18期
117-118
,共2页
冠脉介入治疗(PCI)%脑利钠肽(BNP)%醛固酮(Ald)%预后
冠脈介入治療(PCI)%腦利鈉肽(BNP)%醛固酮(Ald)%預後
관맥개입치료(PCI)%뇌리납태(BNP)%철고동(Ald)%예후
Treatment of percutaneous coronary intervention (PCI)%Brain natriuretic peptide (BNP)%Aldosterone (Ald)%Prognosis
目的 探讨冠脉介入治疗(PCI)对急性心梗患者血浆脑利钠肽(BNP)、醛固酮(Ald)水平以及近期预后的影响,为临床治疗工作提供思路.方法 以我院介入治疗科2014年1月~2014年12月期间行PCI治疗的133例患者作为本组研究的观察对象,按照治疗方法将其分为直接PCI组(57例)与延迟PCI组(47例)以及对照组(29例),直接PCI组给予直接PCI治疗,延迟PCI组给予延迟PCI治疗,对照组给予常规溶栓治疗,随访期6个月,对比三组患者治疗前后的血浆BNP、Ald水平以及近期预后情况.结果 (1)治疗前,三组的血浆BNP、Ald水平之间比较无明显差异,不具有统计学意义,P > 0.05;治疗后,三组的血浆BNP、Ald水平均有所下降,其中直接PCI组与延迟PCI组的血浆BNP、Ald水平明显低于治疗前,且直接PCI组血浆BNP、Ald水平均明显低于延迟PCI组,均具有统计学意义,P < 0.05.(2)随访期内,直接PCI组死亡2例(3.51%),延迟PCI组死亡2例(4.26%),对照组死亡4例(13.79%),直接PCI组与延迟PCI组的死亡率均明显低于对照组,具有统计学意义,P < 0.05.结论 PCI治疗能够明显改善急性心梗患者的血浆BNP与Ald水平,降低临床死亡率,提高近期预后,可以作为急性心梗治疗的首选治疗方案.
目的 探討冠脈介入治療(PCI)對急性心梗患者血漿腦利鈉肽(BNP)、醛固酮(Ald)水平以及近期預後的影響,為臨床治療工作提供思路.方法 以我院介入治療科2014年1月~2014年12月期間行PCI治療的133例患者作為本組研究的觀察對象,按照治療方法將其分為直接PCI組(57例)與延遲PCI組(47例)以及對照組(29例),直接PCI組給予直接PCI治療,延遲PCI組給予延遲PCI治療,對照組給予常規溶栓治療,隨訪期6箇月,對比三組患者治療前後的血漿BNP、Ald水平以及近期預後情況.結果 (1)治療前,三組的血漿BNP、Ald水平之間比較無明顯差異,不具有統計學意義,P > 0.05;治療後,三組的血漿BNP、Ald水平均有所下降,其中直接PCI組與延遲PCI組的血漿BNP、Ald水平明顯低于治療前,且直接PCI組血漿BNP、Ald水平均明顯低于延遲PCI組,均具有統計學意義,P < 0.05.(2)隨訪期內,直接PCI組死亡2例(3.51%),延遲PCI組死亡2例(4.26%),對照組死亡4例(13.79%),直接PCI組與延遲PCI組的死亡率均明顯低于對照組,具有統計學意義,P < 0.05.結論 PCI治療能夠明顯改善急性心梗患者的血漿BNP與Ald水平,降低臨床死亡率,提高近期預後,可以作為急性心梗治療的首選治療方案.
목적 탐토관맥개입치료(PCI)대급성심경환자혈장뇌리납태(BNP)、철고동(Ald)수평이급근기예후적영향,위림상치료공작제공사로.방법 이아원개입치료과2014년1월~2014년12월기간행PCI치료적133례환자작위본조연구적관찰대상,안조치료방법장기분위직접PCI조(57례)여연지PCI조(47례)이급대조조(29례),직접PCI조급여직접PCI치료,연지PCI조급여연지PCI치료,대조조급여상규용전치료,수방기6개월,대비삼조환자치료전후적혈장BNP、Ald수평이급근기예후정황.결과 (1)치료전,삼조적혈장BNP、Ald수평지간비교무명현차이,불구유통계학의의,P > 0.05;치료후,삼조적혈장BNP、Ald수평균유소하강,기중직접PCI조여연지PCI조적혈장BNP、Ald수평명현저우치료전,차직접PCI조혈장BNP、Ald수평균명현저우연지PCI조,균구유통계학의의,P < 0.05.(2)수방기내,직접PCI조사망2례(3.51%),연지PCI조사망2례(4.26%),대조조사망4례(13.79%),직접PCI조여연지PCI조적사망솔균명현저우대조조,구유통계학의의,P < 0.05.결론 PCI치료능구명현개선급성심경환자적혈장BNP여Ald수평,강저림상사망솔,제고근기예후,가이작위급성심경치료적수선치료방안.
Objective Coronary artery interventional therapy (PCI) and short-term prognosis of acute myocardial infarction patients with plasma brain natriuretic peptide (BNP) and aldosterone (ALD) level, provide ideas for clinical treatment.Methods In our hospital interventional treatment of 2014 during January to December 2014 PCI Treatment of 133 patients as the research object of observation, according to the method of treatment wil be the as direct PCI group (57 cases) and delayed PCI group (47 cases) and control group (29 cases), direct PCI group give direct PCI, delayed PCI group received delayed PCI therapy, while the control group was given conventional therapy, folow-up period of 6 months, compared three groups of patients before and after plasma BNP, ALD levels and the recent prognosis.Results (1) Before treatment, between the three groups of plasma BNP, aldosterone levels no significant difference, is not statisticaly significant, (P > 0.05); after treatment, three groups of plasma BNP, aldosterone levels decreased, the direct PCI group and delay PCI group plasma BNP, aldosterone levels were significantly lower than those before treatment and direct PCI group, the plasma BNP, aldosterone levels were significantly lower than delayed PCI group has statistical significance,P < 0.05. (2) During the folow-up period, the direct PCI group died in 2 cases (3.51%), delayed PCI group, 2 cases died (4.26%), died in the control group (n = 4) (13.79%), direct PCI group and delay of the PCI group mortality rates were significantly lower than the control group, with statistical significance,P < 0.05.Conclusion PCI treatment can significantly improve in patients with acute myocardial infarction and plasma BNP and ALD level and reduce the mortality, improve the prognosis and can be used in treatment of acute myocardial infarction (AMI) the preferred treatment in clinical application.
